Tenet Reports Results for the Second Quarter Ended June 30, 2016
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Mizuho Securities Cuts Price Target on Tenet Healthcare (THC) to $28; Reiterates Neutral
August 2, 2016 8:11 AM EDTMizuho Securities maintained a Neutral rating on Tenet Healthcare (NYSE: THC), and cut the price target to $28.00 (from $33.00), following the company's 2Q earnings report.
Analyst Sheryl Skolnick commented, "The Mama issue is not a 'once and done, now it's behind them' thing. It's... More
Tenet Healthcare (THC) Misses Q2 EPS by 14c, Offers FY16 & Q3 Guidance
August 1, 2016 5:18 PM EDTTenet Healthcare (NYSE: THC) reported Q2 EPS of $0.38, $0.14 worse than the analyst estimate of $0.52. Revenue for the quarter came in at $4.87 billion versus the consensus estimate of $4.83 billion.
GUIDANCE:
Tenet Healthcare sees FY2016 EPS of $1.32-$1.67, versus the consensus of $1.93.... More
